• Compound libraries

    Arrow active
  • Products

    Arrow active
  • EBC main page

  • Search

  • Dyes

  • Impurities

  • Chemical probes

  • Contacts us

  • Pfizer reference compounds

  • Services

  • EBC Libraries
    Icon image 1Signaling Pathways and Protein Classes Related Libraries
    • Angiogenesis Related Ligands
    • Apoptosis Related Ligands
    • Cancer Immunology Related Ligands
    • Cell Cycle Related Ligands
    • Epigenetics Related Ligands
    • GPCR-binding Ligands
    • Growth Factors and Cytokines Ligands
    • Hippo signaling pathway ligands
    • Ion Channel Ligands
    • JAK-STAT Signaling Ligands
    • Kinase Inhibitors
    • Kinase Inhibitors Max
    • Membrane Receptor Ligands
    • Neuronal Signaling Related Ligands
    • Nuclear Hormone Receptor Ligands
    • Protease Inhibitors
    • RNA-Binders
    • RNA-Binding Protein Ligands
    • Signal Transduction Related Ligands
    • Transporter Ligands
    Icon image 2Bioactive Screening Compound Libraries
    • Bioactive Compounds I
    • Bioactive Compounds II
    • Bioactive Compounds III
    • Bioactive Compounds Max
    • Flavour and Fragrance Compounds
    • High-Potency Chemical Probes
    • Natural Product Derivatives
    • Natural Products
    • QED Bioactive Compounds
    • Traditional Chinese Medicine Active Compounds
    Icon image 4Disease Related Compound Libraries
    • Anticancer Compounds
    • Antiviral Compounds
    • Cardiotoxic Compounds
    • Most-DILI-Concern Drugs
    • Neurodegenerative Disease Related Compounds
    • Psychoactive Drugs
    Icon image 3Drug Repurposing and Related Libraries
    • Approved Drugs
    • FDA Approved and Potential Drugs
    • FDA Approved Drugs
    • Full Library of FDA Approved Drugs
    • Impurity Reference Standards
    • Investigational Drugs
  • Products
    Libraries
    Signaling Pathways and Protein Classes Related LibrariesDisease Related Compound LibrariesBioactive Screening Compound LibrariesDrug Repurposing and Related Libraries
    Categorized products
    AgonistsInhibitors
    Reagents for Chemical Biology
    Bioorthogonal ReagentsPhotoaffinity Labeling (PAL)
    Bioorthogonal ReagentsPhotoaffinity Labeling (PAL)Drugs & Investigational CompoundsExploratory Compounds & Research ToolsMarine ProductsPesticides and pollutantsPfizer Reference CompoundsAntiviral Compounds
    Drugs and impuritiesChemical probes
    Dyes
  • Drugs & Impurities
  • Chemical probes
  • Services
  • Dyes
  • Search
  • Pfizer reference compounds
LogoEnamine store logo
Logo
  • Terms of Service
  • Privacy Policy
  • Publications
  • Contact us
  • About us
Enamine store logo

© 2026 Copyright Enamine

Back

Product details:

MDK8228

Molecule product

ID

EBC-501086

|

PF-06678920

CAS

1962928-22-8

Purity

95%

MDK8228 is an inhibitor of CBP/p300 and BRD4 bromodomain. It downregulates IL-6, IL-ß and IFN-ß in macrophages.

Properties

cLogP:3.937
MW:531.321

Name

MDK8228

Smiles

CN(C)CCCOC=1C=CC(CCC2=NC=3C=C(C=CC3N2CCN4CCOCC4)C=5C(C)=NOC5C)=CC1

Targets

Please log in to see this information

Licensing Information

Sold for research purposes under agreement from Pfizer Inc.

Synonyms

No records

Transportation & Handlings
Storage temperature:RT
Transport temperature:Standard
Dangerous goods:No
Solubility

No data available

Purity & Quality Control

The compound has purity validated by NMR and/or LCMS methods.

Prices

1 mg

$126

2 mg

$189

5 mg

$377

10 mg

$653

15 mg

$791

20 mg

$930

25 mg

$1130

30 mg

$1331

35 mg

$1532

40 mg

$1733

45 mg

$1859

50 mg

$1984

75 mg

$POA

100 mg

$POA

Quantity

-

1

+

Total amount

$ 377

Your current project

In Stock

Synonyms

No records

Transportation & Handlings
Storage temperature:RT
Transport temperature:Standard
Dangerous goods:No
Solubility

No data available

Purity & Quality Control

The compound has purity validated by NMR and/or LCMS methods.

Target activity features

It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.